You are here:



When conducting studies in patients our flagship offerings are in HIV and TB as well as other Infectious Disease Vaccines and Therapeutics. Our execution partners have recently played a major role in recruiting large patient cohorts (>25,000 randomised) in several SARS-CoV-2 vaccine studies.

Infectious Diseases (Vaccines & Therapeutics)
  • Human Immunodeficiency Virus (HIV)
  • Tuberculosis (TB)
  • Respiratory Syncytial Virus (RSV)
  • Influenza Virus (Seasonal and Pandemic)
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • Varicella-Zoster Virus (VZV; Shingles)
  • Hepatitis Virus (HBV & HCV)
  • Meningococcal Bacteria (Meningococcal Disease)
  • Pneumococcal Bacteria (IPD)

When conducting healthy volunteer studies, we offer First-in-Man and Bioequivalence studies as our flagship offerings. We offer a comprehensive bio-analytical laboratory service, packaged with the clinical procedures, or provided as standalone service.

Healthy Volunteers
  • Bioequivalence and Bioavailability
  • First-in-Man Safety (SAD & MAD)
  • Drug-Drug Interaction
  • Food Effect
  • QT/QTc

In addition to the above, we can also deliver on select chronic disease therapeutic areas specialising in proof-of-concept (Phase 2a) studies in these therapeutic areas.

Autoimmune Disorders
  • Atopic Dermatitis (AD or Eczema) and Psoriasis
  • Crohn’s Disease and Ulcerative Colitis (IBD)
  • Rheumatoid Arthritis (RA)
Chronic Metabolic Disorders (with/out CV complications)
  • Diabetes (Type 1 and 2)
  • Hypercholesterolemia and Hyperlipidaemia
  • Cardiovascular Complications
    • Atherosclerosis (Narrowing/Hardening of Arteries)
    • Coronary Artery Stenosis (Heart Attack)
    • Carotid Artery Stenosis (Stroke)
    • Peripheral Artery Disease
Chronic Respiratory Disorders
  • Asthma (Complicated and Uncomplicated)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Allergic Rhinitis (Hay Fever)
Musculoskeletal Disorders
  • Osteoarthritis (OA)